Prognostic factors in advanced stage Hodgkin's lymphoma: the significance of the number of involved anatomic sitesT. P. Vassilakopoulos, Gerassimos A. Pangalis, Maria K. Angelopoulou et al.|European Journal Of Haematology|2001Cited by 37
Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphomaTheodoros P. Vassilakopoulos, Gerassimos A. Pangalis, Maria K. Angelopoulou et al.|International Journal of Radiation Oncology*Biology*Physics|2004Cited by 24
EBVD Combination Chemotherapy Plus Low Dose Involved Field Radiation is a Highly Effective Treatment Modality for Early Stage Hodgkin's DiseaseMaria K. Angelopoulou, Gerassimos A. Pangalis, Theodoros P. Vassilakopoulos et al.|Leukemia & lymphoma/Leukemia and lymphoma|2000Cited by 21
Pure infradiaphragmatic Hodgkin's lymphoma. Clinical features, prognostic factor and comparison with supradiaphragmatic disease.Theodoros P. Vassilakopoulos, Gerassimos A. Pangalis, Maria K. Angelopoulou et al.|PubMed|2006Cited by 18
Tumor-infiltrating and circulating granulocytic myeloid-derived suppressor cells correlate with disease activity and adverse clinical outcomes in mycosis fungoidesKimon V. Argyropoulos, Marina P. Siakantaris, Melissa Pulitzer et al.|Clinical & Translational Oncology|2019Cited by 16